Metastatic kidney cancer patients who took a proprietary live bacterial supplement showed signs that it could improve their outcomes in a Phase I trial of cabozantinib and nivolumab, according to researchers.
At a time when healthcare providers are facing staff shortages and patients continue to demand better quality of care, AI is being seen as the go-to answer.
Healthcare provider Optum has backed away from its plan to purchase Steward Health Care’s national physicians group, dealing a major setback to Steward’s efforts to bolster its finances after filing for bankruptcy.